465 related articles for article (PubMed ID: 35884412)
1. Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
Lee EW; Khan S
Clin Mol Hepatol; 2017 Dec; 23(4):265-272. PubMed ID: 29113030
[TBL] [Abstract][Full Text] [Related]
3. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
[TBL] [Abstract][Full Text] [Related]
4. New concepts in embolotherapy of HCC.
Pesapane F; Nezami N; Patella F; Geschwind JF
Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
[TBL] [Abstract][Full Text] [Related]
5. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
[TBL] [Abstract][Full Text] [Related]
6. Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis.
Guo J; Wang W; Zhang Y; Xu L; Kong J
J Gastrointest Oncol; 2021 Aug; 12(4):1838-1850. PubMed ID: 34532132
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transarterial bland embolization and drug-eluting beads transarterial chemoembolization for very early and early hepatocellular carcinoma not amenable for surgery or ablation: a single center retrospective data analysis.
Cathomas M; Mueller F; Mertineit N; Baumgartner I; Candinas D; Berzigotti A; Maurer MH; Lachenmayer A
J Gastrointest Oncol; 2023 Oct; 14(5):2167-2177. PubMed ID: 37969817
[TBL] [Abstract][Full Text] [Related]
8. [Transarterial ablation of hepatocellular carcinoma. Status and developments].
Radeleff BA; Stampfl U; Sommer CM; Bellemann N; Hoffmann K; Ganten T; Ehehalt R; Kauczor HU
Radiologe; 2012 Jan; 52(1):44-55. PubMed ID: 22249701
[TBL] [Abstract][Full Text] [Related]
9. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
10. HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
Vogl TJ; Gruber-Rouh T
Dig Dis Sci; 2019 Apr; 64(4):959-967. PubMed ID: 30835030
[TBL] [Abstract][Full Text] [Related]
11. Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.
Nakasumi K; Yamamoto N; Takami T; Itoh H; Itamoto K; Horikirizono H; Iseri T; Nakaichi M; Nemoto Y; Sunahara H; Tani K
J Vet Med Sci; 2022 Jan; 84(1):114-120. PubMed ID: 34866073
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
[TBL] [Abstract][Full Text] [Related]
13. What's New in Transarterial Therapies for Hepatocellular Carcinoma?
May BJ; Murthy R; Madoff DC
Gastrointest Cancer Res; 2012 May; 5(3 Suppl 1):S14-9. PubMed ID: 22876334
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.
Baur J; Ritter CO; Germer CT; Klein I; Kickuth R; Steger U
Hepat Med; 2016; 8():69-74. PubMed ID: 27382341
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
16. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.
Mondaca S; Yarmohammadi H; Kemeny NE
Surg Oncol Clin N Am; 2019 Oct; 28(4):717-729. PubMed ID: 31472915
[TBL] [Abstract][Full Text] [Related]
17. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update.
Kishore SA; Bajwa R; Madoff DC
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224882
[TBL] [Abstract][Full Text] [Related]
18. Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations.
Boily G; Villeneuve JP; Lacoursière L; Chaudhury P; Couture F; Ouellet JF; Lapointe R; Goulet S; Gervais N;
HPB (Oxford); 2015 Jan; 17(1):52-65. PubMed ID: 24961288
[TBL] [Abstract][Full Text] [Related]
19. Conventional
Song JE; Kim DY
World J Hepatol; 2017 Jun; 9(18):808-814. PubMed ID: 28706579
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
